BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29930001)

  • 1. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
    Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
    Roche-Molina M; Sanz-Rosa D; Cruz FM; García-Prieto J; López S; Abia R; Muriana FJ; Fuster V; Ibáñez B; Bernal JA
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):50-9. PubMed ID: 25341796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.
    Vozenilek AE; Vetkoetter M; Green JM; Shen X; Traylor JG; Klein RL; Orr AW; Woolard MD; Krzywanski DM
    J Vasc Res; 2018; 55(2):98-110. PubMed ID: 29455203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STK25 is a critical determinant in nonalcoholic steatohepatitis.
    Amrutkar M; Chursa U; Kern M; Nuñez-Durán E; Ståhlman M; Sütt S; Borén J; Johansson BR; Marschall HU; Blüher M; Mahlapuu M
    FASEB J; 2016 Oct; 30(10):3628-3643. PubMed ID: 27421788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).
    Rautureau Y; Deschambault V; Higgins MÈ; Rivas D; Mecteau M; Geoffroy P; Miquel G; Uy K; Sanchez R; Lavoie V; Brand G; Nault A; Williams PM; Suarez ML; Merlet N; Lapointe L; Duquette N; Gillis MA; Samami S; Mayer G; Pouliot P; Raignault A; Maafi F; Brodeur MR; Levesque S; Guertin MC; Dubé MP; Thorin É; Rhainds D; Rhéaume É; Tardif JC
    Circulation; 2018 Oct; 138(16):1677-1692. PubMed ID: 29674325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.
    Calkin AC; Lee SD; Kim J; Van Stijn CM; Wu XH; Lusis AJ; Hong C; Tangirala RI; Tontonoz P
    Circ Res; 2014 Aug; 115(4):442-9. PubMed ID: 24935961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis.
    Vozenilek AE; Navratil AR; Green JM; Coleman DT; Blackburn CMR; Finney AC; Pearson BH; Chrast R; Finck BN; Klein RL; Orr AW; Woolard MD
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):324-334. PubMed ID: 29217509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
    Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
    J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis.
    Krishnamurthy K; Glaser S; Alpini GD; Cardounel AJ; Liu Z; Ilangovan G
    Cardiovasc Res; 2016 Jul; 111(1):74-83. PubMed ID: 27131506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver.
    Nerstedt A; Kurhe Y; Cansby E; Caputo M; Gao L; Vorontsov E; Ståhlman M; Nuñez-Durán E; Borén J; Marschall HU; Mashek DG; Saunders DN; Sihlbom C; Hoy AJ; Mahlapuu M
    J Lipid Res; 2020 Feb; 61(2):178-191. PubMed ID: 31857389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Hepatic Expression of Endothelial Lipase Inhibits Cholesterol Diet-Induced Hypercholesterolemia and Atherosclerosis in Transgenic Rabbits.
    Wang C; Nishijima K; Kitajima S; Niimi M; Yan H; Chen Y; Ning B; Matsuhisa F; Liu E; Zhang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1282-1289. PubMed ID: 28546217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR
    Thompson D; Morrice N; Grant L; Le Sommer S; Lees EK; Mody N; Wilson HM; Delibegovic M
    Clin Sci (Lond); 2017 Oct; 131(20):2489-2501. PubMed ID: 28899902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.